Place in Antipsychotic Classification
To understand chlorpromazine, it is essential to review the general classification of typical antipsychotics. Traditionally, these agents are divided into three major groups based on their chemical structure.
The largest group is the phenothiazine derivatives, which are further classified by their side-chain structure:
- Aliphatic derivatives: This subgroup includes Chlorpromazinum (chlorpromazine) as well as levomepromazine.
- Piperazine derivatives: This category includes perphenazine, trifluoperazine, and fluphenazine.
- Piperidine derivatives: Represented by thioridazine and pipotiazine.
In addition to phenothiazines, there are butyrophenone derivatives (which include potent neuroleptics such as haloperidol and droperidol) and thioxanthene derivatives (represented primarily by chlorprothixene).
Pharmacological Profile and Central Effects
The spectrum of action of aliphatic phenothiazines includes several clinically significant effects mediated by various brain structures. Notably, chlorpromazine's primary antipsychotic potency is significantly lower than that of haloperidol.
- Antipsychotic effect. This is the drug's primary clinical property. It blocks postsynaptic dopamine $D_2$ receptors, acting primarily in the brain's mesolimbic system. This blockade eliminates positive psychotic symptoms, relieving delusions and hallucinations.
- Sedative effect. The drug exerts a powerful calming action. This mechanism is independent of dopamine: sedation occurs because the active substance depresses the ascending reticular activating system located in the brainstem.
- Additional effects. The drug has antiemetic and anxiolytic (antianxiety) properties. A key characteristic is potentiation: chlorpromazine enhances the effects of other central nervous system depressants, including general anesthetics, sedatives, and opioid analgesics.
Effects on the Peripheral and Autonomic Nervous System
Drugs with prominent central effects often impact the peripheral nervous system (nerve fibers, synapses, and organ tissues), leading to adverse reactions. Chlorpromazine actively affects the autonomic nervous system, demonstrating combined alpha-blocking and anticholinergic activities.
- Effects on cholinergic receptors: The drug exhibits pronounced muscarinic receptor antagonism. Interestingly, this effect is significantly weaker in haloperidol.
- Effects on vascular tone: As a neuroleptic, chlorpromazine simultaneously blocks peripheral $\alpha$-adrenoreceptors. A direct consequence of this blockade is the relaxation of vascular smooth muscle (vasodilation), which manifests clinically as a sharp drop in blood pressure.
Characteristic Side Effects
The use of typical antipsychotics is inextricably linked to a high risk of severe complications affecting motor function and endocrine balance.
Extrapyramidal Symptoms (EPS) This is a classic clinical hallmark of typical neuroleptics. Patients taking chlorpromazine or haloperidol have a very high probability of developing drug-induced parkinsonism, dystonias, and various dyskinesias.
Neuroendocrine Disorders Chlorpromazine specifically affects the pituitary gland, increasing prolactin secretion from the anterior lobe. The mechanism is as follows: under normal conditions, dopamine acts as a prolactin-inhibiting factor. When chlorpromazine blocks $D_2$ receptors, this inhibitory influence of dopamine is removed, and hormone levels rise uncontrollably (hyperprolactineamia).
Clinical consequences of this hormonal shift include:
- Increased lactation with spontaneous milk flow from the breasts (galactorrhea).
- Enlargement of male breast tissue (gynecomastia).
- Decreased gonadotropin production, which in turn provokes impotence in men and severe menstrual irregularities (up to amenorrhea) in women.